{"title":"Atherogenic dyslipidemia as a novel cardiovascular risk stratification tool in chronic obstructive pulmonary disease: a hospital-based cross-sectional study.","authors":"Sanchit Mehta, Rajvi Kalpesh Baxi, Parina Manish Rathi, Hetvi Rajesh Pabari, Dhairya Hitesh Shah, Pratik Raghavani, Ajay Rajput","doi":"10.4081/monaldi.2026.3802","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3802","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) is characterized by progressive airway obstruction and systemic inflammation, frequently accompanied by metabolic comorbidities, including dyslipidemia. The Atherogenic Index of Plasma (AIP), calculated as log10[triglycerides/high-density lipoprotein (HDL)-cholesterol], is strongly associated with atherosclerotic cardiovascular disease risk, yet its relationship with COPD-associated dyslipidemia remains underexplored. This study investigates the association between atherogenic dyslipidemia profiles and COPD duration, utilizing AIP as an evaluation metric. A hospital-based cross-sectional analytical study was conducted among 100 COPD patients without acute exacerbations. Fasting serum lipid profiles were analyzed using standardized protocols, and AIP was calculated for each participant. Patients were stratified into three AIP risk categories: low risk (AIP<0.21), moderate risk (AIP 0.21-0.5), and high risk (AIP>0.5). Associations between COPD duration, smoking status, demographic variables, and lipid parameters were examined using chi-square analysis. 60% of COPD patients demonstrated high atherogenic index profiles (AIP>0.5), indicating substantial cardiovascular risk. A significant positive correlation was found between COPD duration and AIP (r=0.456, p<0.001), as well as with triglycerides (r=0.341, p<0.001) and low-density lipoprotein-cholesterol (r=0.405, p<0.001). Conversely, COPD duration demonstrated a nonsignificant trend toward an inverse correlation with HDL-cholesterol (r=-0.173, p=0.089). Seventy-one percent of patients demonstrated low HDL-cholesterol (<40 mg/dL). Smoking status was significantly associated with elevated very low-density lipoprotein-cholesterol (p=0.002). The high prevalence of atherogenic dyslipidemia in COPD patients, as quantified by AIP, suggests that lipid profile alteration is progressive and correlates with disease duration. AIP represents a clinically relevant, cost-effective screening tool for identifying COPD patients at elevated cardiovascular risk, facilitating early intervention and personalized risk stratification strategies.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Utility of pleural fluid biomarkers in differentiating malignant and benign pleural effusion: a cross-sectional study.","authors":"Nishant Kumar Chauhan, Yogendra Singh Rathore, Mithu Banerjee, Naveen Dutt, Gopal Durgeshwar, Iyer Hariharan","doi":"10.4081/monaldi.2026.3731","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3731","url":null,"abstract":"<p><p>As cytopathological examination of the pleural fluid (PF) has a low yield, it is difficult to differentiate benign from malignant pleural effusions (PEs). There is still a lack of biomarkers in PF that can reliably help in diagnosing malignant PEs. Diagnostic accuracy in diagnosing malignant PEs is enhanced by the presence of tumor markers in PE. This would raise the likelihood of diagnosing malignant PEs with an unclear cause and starting treatment interventions early to lower morbidity and death rates in the patient. Thus, in an effort to enhance the PE diagnosis, novel PF biomarkers such as cancer ratio, cancer ratio plus, carcinoembryonic antigen (CEA), cancer antigen 125 (CA-125), and calprotectin were evaluated. A total of 108 patients with PEs were taken, and after applying inclusion and exclusion criteria, 83 patients with exudative PE were evaluated. After clinical history and routine blood investigations, PF was sent for cytopathology, biochemical examinations, microbiological examinations for aerobic culture, fungal culture, mycobacterial culture, and biomarker (CEA, CA-125, calprotectin) analyses. Out of 83 patients with exudative PE, malignant effusion was diagnosed in 40 patients, while 43 had benign effusions. PF biomarkers adenosine deaminase (ADA), CEA, cancer ratio, calprotectin, age/ADA and serum lactate dehydrogenase (LDH)/calprotectin ratio showed a statistically significant (p<0.0001) difference between benign and malignant PE. PF CEA showed the highest specificity (97.67%) at the cut-off point of 1.96 ng/mL and age/ADA ratio showed the highest sensitivity (97.5%) at the cut-off point of 1.56 for prediction of malignancy. Cancer ratio, PL calprotectin and serum LDH/calprotectin ratio also showed good sensitivity and specificity for the prediction of malignancy. PF CA-125 showed poor sensitivity (50%) and cancer ratio plus did not reveal any statistically significant difference for prediction of malignancy from benign effusion (p=0.486). PF biomarkers (cancer ratio, CEA, age/ADA ratio, calprotectin, and serum LDH/calprotectin ratio) are reliable indicators of malignancy in exudative pleural effusions. Patients with exudative lymphocytic with unexplained pleural effusion can be addressed early using inexpensive and generally available biochemical indicators, such as pleural fluid CEA, calprotectin, cancer ratio, and serum LDH/calprotectin ratio.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ngakan Putu Parsama Putra, Anthony Christanto, Muhammad Iqbal, Adlan Pratama Binharyanto, Cleine Michaela, Mohammad Faridza Setyohadikusumah
{"title":"Beyond vascular endothelial growth factor: synergistic diagnostic value of multiple biomarkers in malignant pleural effusion. A cross-sectional analytical study<b />.","authors":"Ngakan Putu Parsama Putra, Anthony Christanto, Muhammad Iqbal, Adlan Pratama Binharyanto, Cleine Michaela, Mohammad Faridza Setyohadikusumah","doi":"10.4081/monaldi.2026.3688","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3688","url":null,"abstract":"<p><p>Malignant pleural effusion (MPE) remains a challenging diagnostic entity within the vast spectrum of pleural effusions. While vascular endothelial growth factor (VEGF) is a widely studied MPE biomarker, its diagnostic performance as a standalone marker is limited. There is growing interest in evaluating whether combined biomarker panels may provide incremental diagnostic information and reduce diagnostic uncertainty. This study aims to explore whether integrating matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1), and monocyte chemoattractant protein-1 (MCP-1) into VEGF provides incremental diagnostic value in distinguishing malignant from benign pleural effusions. A total of 88 pleural fluid samples were analyzed (33 malignant, 55 benign). Biomarker levels were measured using enzyme-linked immunosorbent assay. Diagnostic performance was assessed via receiver operating characteristic analysis, with optimal cut-off values identified using the Youden Index. Logistic regression models were developed for combined biomarker panels and internally validated using 5-fold cross-validation. VEGF demonstrated moderate individual diagnostic value (area under the curve 0.640; sensitivity 72.7%; specificity 58.2%; and diagnostic odds ratio of 3.71). Other individual markers showed limited accuracy. The four-marker panel (VEGF + MMP-9 + TIMP-1 + MCP-1) showed a modest increase in sensitivity, negative predictive value, and diagnostic odd ratio, although specificity remains limited. These findings suggest that combined pleural fluid biomarkers may provide incremental diagnostic information, but their performance remains modest and requires external validation before clinical application.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gautam Prem, Dimple Kumar Bhaglani, R S Negi, Surya Tej P V, Himmat Singh Pannu
{"title":"Diagnostic predictors of tuberculosis in exudative pleural effusion patients with intermediate adenosine deaminase values: a retrospective diagnostic prediction model study.","authors":"Gautam Prem, Dimple Kumar Bhaglani, R S Negi, Surya Tej P V, Himmat Singh Pannu","doi":"10.4081/monaldi.2026.3828","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3828","url":null,"abstract":"<p><p>Adenosine deaminase (ADA) in pleural fluid is widely used to support the diagnosis of tuberculous pleural effusion. However, ADA levels between 40 and 60 IU/L represent a gray area where both tuberculous and non-tuberculous conditions can coexist. It can potentially lead to empirical antitubercular therapy and a delay in the diagnosis of other conditions. The aim of this study was to create and validate a prediction model to improve the diagnosis of tuberculosis (TB) in patients with exudative pleural effusions and intermediate ADA levels. This retrospective diagnostic modeling study included 125 consecutive adults with exudative pleural effusions, meeting Light's criteria, and pleural fluid ADA levels between 40 and 60 IU/L. These patients were referred to a tertiary respiratory care center in northern India. Univariable receiver operating characteristic curve analysis was used to shortlist candidate predictors with an area under the curve (AUC) of ≥0.60 and p≤0.05. A multivariable logistic regression model was developed using the forward stepwise procedure, including ADA, pleural fluid protein, and patient age. The performance of the model was assessed for discrimination, calibration, and classification and compared to the performance of ADA alone. Internal validation was done using 10-fold stratified cross-validation. Of 125 patients, 77 (62%) had TB and 48 (38%) had non‑TB aetiologies (malignancy ≈30%; acute inflammatory/parapneumonic effusion ≈12%; chronic inflammatory conditions ≈6%). The 3‑predictor model achieved an AUC of 0.89 [95% confidence interval (CI) 0.83-0.95] and an overall accuracy of 85%, with sensitivity 89%, specificity 79%, positive predictive value 84% and negative predictive value 86% at a probability cut‑off of 0.50. ADA alone yielded an AUC of 0.72 (95% CI 0.62-0.82) and accuracy of 68%, with sensitivity 70% and specificity 65%. Ten‑fold stratified cross‑validation showed stable performance (mean cross‑validated AUC 0.87±0.04; optimism 0.02). Independent predictors were ADA [odds ratio (OR) 1.24 per IU/L], protein (OR 1.65 per g/dL) and age (OR 0.93 per year; all p<0.001). In exudative pleural effusions with an ADA level of intermediate values, a simple model combining ADA, pleural protein concentration, and patient age improves the diagnostic discrimination for TB over ADA alone, with a marked improvement in negative predictive probability. External validation in a prospective multicenter study is needed before its use in clinical practice.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francesco Ardesi, Paolo Delvino, Marco Vanetti, Martina Zappa, Patrizia Pignatti, Rosella Centis, Veronica Capuano, Alessandro Maria Marra, Francesco Bini, Stefania Gallo, Giulia Franzini, Daniela Gallo, Eliana Piantanida, Nicola Sverzellati, Antonio Spanevello, Dina Visca
{"title":"Addressing unmet needs in uncontrolled asthma through a specialized severe asthma center<b />.","authors":"Francesco Ardesi, Paolo Delvino, Marco Vanetti, Martina Zappa, Patrizia Pignatti, Rosella Centis, Veronica Capuano, Alessandro Maria Marra, Francesco Bini, Stefania Gallo, Giulia Franzini, Daniela Gallo, Eliana Piantanida, Nicola Sverzellati, Antonio Spanevello, Dina Visca","doi":"10.4081/monaldi.2026.3908","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3908","url":null,"abstract":"<p><p>Severe asthma represents a clinically challenging proportion of the asthma population, characterized by persistent symptoms, frequent exacerbations, and a higher healthcare burden. To address the complexity of uncontrolled disease, specialized severe asthma clinics have emerged as key models for delivering precision medicine through multidimensional assessment and tailored interventions. This paper describes the organization, clinical approach, and multidisciplinary framework of a tertiary Severe Asthma Centre established in Northern Italy in 2017. The center integrates prioritized outpatient access with a structured day-hospital program (Complex Outpatient Macro Activity, MAC), enabling accelerated diagnostic work-up, comprehensive phenotyping/endotyping, and repeated educational interventions. Central elements include confirmation of diagnosis, assessment of type 2 inflammatory biomarkers (FeNO, IgE, blood and sputum eosinophils), evaluation of airway inflammation, and systematic identification of pulmonary and extrapulmonary treatable traits. A broad multidisciplinary network supports the management of comorbidities such as allergic rhinitis, chronic rhinosinusitis, hypereosinophilic disorders, allergic bronchopulmonary aspergillosis, metabolic and endocrine complications, gastroesophageal reflux disease, and vocal cord dysfunction. Pulmonary rehabilitation is integrated as an adjunctive intervention, particularly for patients with severe disease. Our severe asthma clinic implements precision medicine and the treatable traits approach in clinical practice to optimize outcomes, rationalize biologic therapy use, and reduce glucocorticoid exposure. Future perspectives include expansion toward a \"united airways disease\" clinic, integrating upper and lower airway management to further improve care for complex inflammatory airway diseases.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Determinants of delayed pulmonary tuberculosis diagnosis in a rural district of Pakistan.","authors":"Amin Ur Rahman, Zia Qamar, Afnan Fayaz, Bushra Arif, Ihtisham Habib, Wareesha Naeem Aurakzai","doi":"10.4081/monaldi.2026.3782","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3782","url":null,"abstract":"<p><p>Tuberculosis (TB) caused by acid-fast bacilli is one of the leading causes of morbidity and mortality in developing countries. Pakistan has the world's fifth-largest prevalence of TB, with 276/100,000 cases in prevalence and a mortality of 34/100,000. Delayed diagnosis, disruptions in treatment continuity and a lack of awareness are the key issues leading to multidrug-resistant TB. The current study aimed to find out the determinants of delayed pulmonary TB in a rural district of Khyber Pakhtunkhwa Province, Pakistan. The cross-sectional study was conducted in six TB control program centers designated by the National TB Control Program from March to December 2024. Data were collected from 250 eligible patients, and after removal of incomplete questionnaires, the data of 229 patients were analyzed. The study was approved by the district TB officer, and participants' consent was obtained before data collection. A delay of >21 days was considered the cutoff point for delayed TB diagnosis. Among 229 patients, 51.1% were male and 48.9% female participants, with a mean age of 33.31±21.32 years. The mean diagnostic delay was 23.66±14.94 days. Descriptive analysis of data showed 52% of delayed TB diagnosis cases; 92.2% of the studied patients were from rural areas, in which 80% of delayed TB diagnosis cases were reported. Male gender [odds ratio (OR)=2.31], getting treatment from public hospitals (OR=4.13), age group 31-45 years (OR=3.10), presence of acute extrapulmonary symptoms of cough, fever, and weight loss (OR=2.84), perception that the symptoms will be relieved by oneself (OR=9.99), economic constraints (OR=6.58), and perception of the poor quality of healthcare services at hospitals (OR=7.32) were found to be significant factors of delayed TB diagnosis. Primary school- (OR=0.20), college- or university-level education (OR=0.42) and high-income groups (OR=0.39) were significant protective factors against delayed TB diagnosis. Marital status, occupation, residence, comorbidities, distance from healthcare facility, previous exposure to TB patients, fever, weight loss, chronic cough, hemoptysis, fear of diagnosis, fear of social isolation, and bad experience of the healthcare staff behavior were found to be non-significant factors for delayed TB diagnosis. The study only focused on delayed diagnosis and did not report healthcare system-related or total delay in tuberculosis management. The study affirmed the significant impact of patient perceptions and socioeconomic status on delayed TB diagnosis.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exploring the periodontal health status and level of matrix metalloproteinases in patients with interstitial lung disease: a case control study.","authors":"Prerna S Hirkane, Umesh Pratap Verma, Ajay Kumar Verma, Pavitra Rastogi, Ashutosh Shrivastava, Anjani Kumar Pathak","doi":"10.4081/monaldi.2026.3753","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3753","url":null,"abstract":"<p><p>Periodontitis has been linked to several respiratory diseases such as chronic obstructive pulmonary disease, asthma, and lung cancer; however, the role of periodontal health status and matrix metalloproteinases (MMPs) in interstitial lung diseases (ILDs) remains largely unexplored. The present study aimed to investigate periodontal health and evaluate serum and salivary levels of MMP-7, MMP-8, and tissue inhibitor of metalloproteinase-1 (TIMP-1) in patients with ILDs. A total of 75 individuals were included and divided equally into three groups: healthy controls, patients with chronic periodontitis, and patients with ILDs. Demographic factors such as age, gender, and socioeconomic status were recorded, along with clinical parameters including plaque index, gingival index, probing pocket depth, and clinical attachment level. The findings revealed that levels of MMP-7 and MMP-8 were significantly elevated in both the periodontitis and ILD groups compared to healthy controls, while TIMP-1 did not show notable variation among groups. Clinical periodontal parameters were also higher in patients with ILDs as well as those with chronic periodontitis. These results suggest a possible link between ILD and chronic periodontitis, both from clinical and biochemical perspectives. The study provides pioneering evidence in the emerging field of oral-systemic research, emphasizing the need for further investigations with larger sample sizes and interventional designs to strengthen the evidence base and explore possible genetic associations underlying this relationship.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hypertension cost in primary health care facilities in Morocco: a cost-of-illness study.","authors":"Soumaya Benmaamar, Moncef Maiouak, Ibtissam El Harch, Angela Christie Filankembo Kava, Passy Conde, Khalid Khilou, Noura Qarmiche, Samira El Fakir, Mohamed Berraho, Nabil Tachfouti","doi":"10.4081/monaldi.2026.3816","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3816","url":null,"abstract":"<p><p>Hypertension in low- and middle-income countries such as Morocco has an economic importance due to its high prevalence and cost. The aim of this study is to estimate direct health costs (DHC) for hypertension patients followed in primary health care facilities in Morocco. A cost of illness prevalence-based study was carried out on hypertension patients followed in public primary health care facilities in Fez. Data were collected using a questionnaire, including sociodemographic and clinical data and healthcare resources utilization: medical tests, medications, and medical visits. DHC was estimated using a bottom-up approach method from a societal perspective and a one-year time horizon. Official prices published by the national agency for health insurance were adopted as unit costs. Cost was compared to annual household income for calculating the catastrophic cost. Cost is defined as catastrophic if it exceeds 10% of annual household income. We included 146 patients. The mean age was 60.7±11.1 years; 70.5% were men. More than half (54.2%) of participants had uncontrolled hypertension. The direct medical cost was estimated at 368.8±120.8 United States dollars per patient. Costs of medical tests and drugs represented, respectively, 58.6% and 30.5% of total direct cost. The incidence of catastrophic cost was 76.8%. Hypertensive patients incur substantial direct costs. High rates of catastrophic costs illustrate the urgency of improving financial risk protection for these patients and strengthening primary care to ensure the affordability of hypertension care.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marco Contoli, Marco Biagini, Paolo Onorati, Giovanni Sotgiu, Roberto Trevisan, Walter Castellani
{"title":"The Italian Community-based Pulmonology Manifesto: a national survey exploring the current state, critical issues, and perspectives for a national reference model.","authors":"Marco Contoli, Marco Biagini, Paolo Onorati, Giovanni Sotgiu, Roberto Trevisan, Walter Castellani","doi":"10.4081/monaldi.2026.4135","DOIUrl":"https://doi.org/10.4081/monaldi.2026.4135","url":null,"abstract":"<p><p>In Italy, demographic aging, increasing multimorbidity, and the growing burden of chronic respiratory conditions have highlighted the need for a reorganization of community-based respiratory services, as outlined by the Italian Ministerial Decree 77/2022, which promotes integrated, proximity-based models of care. Community-based pulmonology care represents a potentially pivotal component of healthcare systems for the management of chronic and complex respiratory diseases. A national, anonymous, web-based survey was conducted among Italian pulmonologists working in territorial and community healthcare settings. The questionnaire explored organizational structures, clinical and diagnostic activities, availability of technological resources, care pathways, continuity of care, and integration with hospital services. A total of 168 valid questionnaires were collected and analyzed using descriptive methods. The survey revealed substantial heterogeneity across regions and healthcare organizations in terms of structural models, availability of diagnostic and interventional procedures, multidisciplinary teams, and access to telemedicine solutions. While several community services provide advanced outpatient and home-based respiratory care, significant gaps persist in standardized care pathways, timely access to functional respiratory diagnostics, and structured follow-up of chronic patients. Limitations in direct access to hospitalization pathways further contribute to fragmentation of care and potentially optimizable use of emergency medical services. This survey provides an initial, comprehensive overview of the current state of community-based pulmonology in Italy. The collected data represent a foundational framework for further in-depth analyses aimed at defining shared minimum standards, strengthening hospital-community integration, and supporting the development of a more equitable, efficient, and patient-centered model of respiratory care.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Krishna Priya C V, Lakshmi Ramamoorthy, Pratap Upadhya, H T Lalthanthuami
{"title":"Impact of self-management interventions initiated during hospitalization on inhaler adherence and functional outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial.","authors":"Krishna Priya C V, Lakshmi Ramamoorthy, Pratap Upadhya, H T Lalthanthuami","doi":"10.4081/monaldi.2026.3695","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3695","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) remains a leading global health burden, with acute exacerbations accelerating functional decline and impairing quality of life. Reduced inhaler adherence is a well-recognized contributor to exacerbations and poorer outcomes in COPD. While self-management interventions are well established in stable COPD, their initiation during acute exacerbations has been inadequately explored. This randomized controlled trial, conducted in a South Indian tertiary hospital between July 2024 and May 2025, evaluated the effectiveness of a structured self-management program initiated during hospitalization for acute exacerbation of COPD. The intervention included individualized counseling, family engagement, structured telephonic follow-ups (weekly for 3 months, then monthly for 3 months), and scheduled outpatient reviews, while controls received standard care. Primary outcomes were inhaler adherence assessed by the Test of Adherence to Inhalers, health-related quality of life (HRQoL) measured with the St. George's Respiratory Questionnaire (SGRQ), and functional capacity assessed by the six-minute walk test. At six months, good inhaler adherence was observed in 66.7% of the intervention group compared to 10% of controls (p<0.001). The mean between-group difference in six-minute walk distance at six months was 92.8 meters [95% confidence interval (CI): 58.1 to 127.6; p<0.001], favoring the intervention group. HRQoL also improved significantly, with a mean between-group difference in SGRQ score of -38.2 (95% CI: -46.7 to -29.8; p<0.001). These findings indicate that initiating structured self-management during hospitalization for acute exacerbation of COPD results in significant improvements in inhaler adherence, functional capacity, and quality of life. Integrating self-management into acute care pathways may therefore optimize patient-centered outcomes in this high-risk population.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148563556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}